Navigation Links
XLHealth Appoints New Vice President of Contracting and Provider Relations
Date:7/1/2009

BALTIMORE, July 1 /PRNewswire/ -- XLHealth, owner of one of the nation's largest Medicare chronic condition special needs plans and a leader in improving the quality of care for seniors with chronic illness, announced today that it has appointed Karl Broussard to serve as its vice president of contracting and provider relations. In his new position, Broussard is responsible for the establishment, strategic planning, and management for the company's Medicare Advantage chronic condition Special Needs Plan, Care Improvement Plus. He will also oversee the development and management of relationships with key medical groups, hospitals, and physicians contracted with Care Improvement Plus in the six states in which it operates.

Broussard has more than 25 years' experience in the healthcare, business, and finance industries. Prior to joining XLHealth, Broussard served nine years in various executive roles at Coventry Health Care, most recently as vice president of network development with the company's Vista health plan. In that role, he managed all aspects of Vista's Health Plan network operations and network development as well as Coventry owned non Health Plan products and entities. This oversight included HMO, PPO, Individual, Medicare, Medicaid, Healthy Kids, and Workers' Compensation products for the state of Florida. Broussard's experience also includes positions with Independent Physician Strategies, MedPartners, Inc., FamilyPlus Health Plans of Georgia, Inc., and First Health, Inc.

"Karl brings a wealth of experience in the network development sector to his position," said Lee Spruiell, Senior Vice President of Field Operations for XLHealth. "We are excited to bring him on board to help us continue our commitment to bringing high-quality services to the providers we work with."

Broussard received a Bachelor's of Science degree in accounting from Nicholls State University in Thibodaux, Louisiana, a Masters of Business Administration from the University of Southern Mississippi in Hattiesburg, MS and a Masters of Science in Health Care Policy and Administration from Mercer University in Atlanta, Georgia.

About XLHealth

XLHealth (http://www.xlhealth.com), a Baltimore-based organization focused on improving the healthcare of chronically ill seniors, is the owner and operator of Care Improvement Plus, one of the nation's largest chronic condition special needs plans. Care Improvement Plus provides a complete Medicare Advantage Part D health plan including disease management services to Medicare beneficiaries living with heart failure, diabetes, chronic obstructive pulmonary disease and/or end-stage renal disease. XLHealth has earned Full Accreditation from the National Committee for Quality Assurance (NCQA) under its standards for patient and practitioner-oriented accreditation of disease management programs.


'/>"/>
SOURCE XLHealth
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. XLHealth Statement on Social Security and Medicare Trustees Report
2. XLHealth Statement on Senate Finance Committee Roundtable on Healthcare Reform
3. XLHealth Appoints New CFO, Adds Two Additional Executives
4. XLHealth Corporation Announces Executive Changes
5. Wisconsin Tobacco Tax Increase Is Positive Step for Health, but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs
6. Verathon Inc. Appoints Kendall Stever as Chief Financial Officer
7. Tyco Electronics Appoints Cuong Do as Senior Vice President, Corporate Strategy & Business Development
8. Symmetry Medical Appoints Chairman and Two Directors
9. GBS/CIDP Foundation International Appoints Patricia A. Bryant as Executive Director
10. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
11. Cinergy Health Appoints Dr. Erika Schwartz as Medical Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... ... Wednesday, August 16, to community partners. The newly renovated ER was designed with ... for minor emergencies, eight semi-private rooms to deliver patient results, improve efficiencies and ...
(Date:8/17/2017)... ... August 17, 2017 , ... ... to Healing Through Forgiveness ($15.99, paperback, 9781498497626; $7.99, eBook, 9781498497633) focuses on ... inner healing of memories and achieve forgiveness, through a progressive journey toward healing. ...
(Date:8/17/2017)... ... , ... Advice Media, the industry leader in digital marketing for medical practices, has been recognized ... included in the Inc. 5000 for the second time in two years. Shawn Miele, Chief ... 5000 rankings for the second year in a row. It’s extremely difficult to make this ...
(Date:8/16/2017)... ... ... Summer days spent with family are priceless. Since August is Family Fun Month, ... season of sunshine. Add trying something new to this summer’s bucket list. Whether it’s ... fun. , Try Something New , Choose an activity the whole ...
(Date:8/16/2017)... ... ... Ten outstanding teachers in the Greater Houston area will be named one ... by a Houston Texans player, two tickets to a Texans game, and other prizes. ... texanschecking.com/stars to nominate their favorite teacher with an essay of no more than 500 ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... LOVELAND, Colo. , July 26, 2017 ... Tristan Guttridge and the Bimini SharkLab to custom design the ... diagnostic images of sharks in their native habitat. In ... for Discovery Channel,s Shark Week, Dr. Guttridge approached ... to take pregnancy diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology: